To determine whether DNA-PKCS is a downstream target of nuclear bFGF in our TN breast cancer chemo-resistance model, we determined the expression level of DNA-PKCS in chemotherapy-enriched TN tumor cells. The gene discussed is FGF2; the disease is breast cancer.